Hepatitis C Trial, RecruitingNCT03685045Sponsor: Kirby InstituteCondition: Hepatitis C
Printed from Voxsanity (voxsanity.com.au) — NCT03685045 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
AI generated eligibility summary.
Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source.
How we use AI
Who might be able to join this trial:
You are willing to take part and have signed an agreement form saying so
You are 18 years old or older
You have a history of using drugs by injection
You have injected drugs in the past six months, OR you are currently on a medication-assisted treatment programme to help with drug use (note: if you are being recruited through a residential rehabilitation centre, the last two requirements may not apply to you)
Who may not be able to join:
There are no stated reasons that would stop someone from joining this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Principal Investigator: Jason Grebely, The University of New South Wales
Canberra Alliance for Harm Minimisation & Advocacy (CAHMA), Canberra, Australian Capital Territory
Blacktown Methadone Management Clinic, Blacktown, New South Wales
NSLHD Brookvale Community Health Centre, Brookvale, New South Wales
Campbelltown Drug Health Services, Campbelltown, New South Wales
HNELHD Drug and Alcohol Clinical Services Cessnock, Cessnock, New South Wales
MNCLHD Coffs Harbour Alcohol and Other Drug Services, Coffs Harbour, New South Wales
Rankin Court Treatment Centre, Darlinghurst, New South Wales
NNSWLHD Grafton Alcohol and Other Drug Services, Grafton, New South Wales
NBMLHD Drug & Alcohol Services Katoomba, Katoomba, New South Wales
MNCLHD Kempsey Alcohol and Other Drug Services, Kempsey, New South Wales
NNSWLHD Lismore (Riverlands) Alcohol and Other Drug Services, Lismore, New South Wales
NBMLHD Drug & Alcohol Services Lithgow, Lithgow, New South Wales
Liverpool Opioid Treatment Program, Liverpool, New South Wales
WSLHD Mount Druitt Drug Health OST Clinic, Mount Druitt, New South Wales
HNELHD Drug and Alcohol Clinical Services Newcastle, Newcastle, New South Wales
Lawrence Avenue Methadone Program (LAMP), Nowra, New South Wales
WSLHD Fleet Street Drug Health OST Clinic, Parramatta, New South Wales
MNCLHD Port Macquarie Alcohol and Other Drug Services, Port Macquarie, New South Wales
NSLHD Herbert Street Clinic, Saint Leonards, New South Wales
HNELHD Drug and Alcohol Clinical Services Tamworth, Tamworth, New South Wales
HNELHD Drug and Alcohol Clinical Services Taree, Taree, New South Wales
NNSWLHD Tweed Heads Alcohol and Other Drug Services, Tweed Heads, New South Wales
The Orana Centre, Wollongong, New South Wales
Biala City Community Health Centre, Brisbane, Queensland
Youthlink, Cairns, Queensland
Queensland Injectors Health Network (QuIHN), Kirwan, Queensland
Townsville Sexual Health Services, North Ward Health Campus, Townsville, Queensland
Northern Drug and Alcohol Services South Australia (DASSA), Elizabeth, South Australia
Central Drug and Alcohol Services South Australia (DASSA), Stepney, South Australia
Next Step Fremantle, Fremantle, Western Australia
Next Step Joondalup, Joondalup, Western Australia
Next Step East Perth, Perth, Western Australia
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Voxsanity
Clinical trials and treatments, explained plainly · voxsanity.com.au
Date:
To: My Doctor
Re: Clinical trial enquiry
I am writing to enquire about the following clinical trial which may be relevant to my care:
Trial: NCT03685045
Sponsor: Kirby Institute
Phase: Not Applicable
Status: Recruiting
Condition: Hepatitis C
Trial contact: +61 2 9385 0878
More information: https://clinicaltrials.gov/study/NCT03685045
Eligibility summary (AI generated)
Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.
Who might be able to join this trial:
You are willing to take part and have signed an agreement form saying so
You are 18 years old or older
You have a history of using drugs by injection
You have injected drugs in the past six months, OR you are currently on a medication-assisted treatment programme to help with drug use (note: if you are being recruited through a residential rehabilitation centre, the last two requirements may not apply to you)
Who may not be able to join:
There are no stated reasons that would stop someone from joining this trial
Important: Always verify eligibility with the trial site directly before applying.
Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.
This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Kirby Institute
Registry
ClinicalTrials.gov
Start date
28 May 2018
Est. completion
31 December 2026
Where this trial is recruiting
🇦🇺 Australia
32 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Number of participants commencing anti-HCV treatment
Can't join this trial?
Expanded access pathways
If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.